Lexicon Pharmaceuticals Inc
F:LX31
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lexicon Pharmaceuticals Inc
F:LX31
|
US |
|
F
|
Fraport Frankfurt Airport Services Worldwide AG
DUS:FRA
|
DE |
|
Gunnison Copper Corp
TSX:GCU
|
US |
|
A
|
American Homes 4 Rent
F:A4XA
|
US |
|
Sandvik AB
OTC:SDVKF
|
SE |
|
A
|
Advanced Micro Devices Inc
XHAM:AMD
|
US |
|
Providence Resources PLC
OTC:PVDRF
|
IE |
|
M
|
Mayr Melnhof Karton AG
XMUN:MYM
|
AT |
|
G
|
Goldman Sachs Group Inc
XBER:GOS
|
US |
|
C
|
City Developments Ltd
OTC:CDEVF
|
SG |
|
Rinnai Corp
OTC:RINIF
|
JP |
|
Lepanto Consolidated Mining Co
OTC:LECBF
|
PH |
Bankruptcy Probability
Lexicon Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lexicon Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
|
991.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lexicon Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lexicon Pharmaceuticals Inc has total debt of 49.7m USD. This includes both short-term (0 USD) and long-term (49.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
